138 related articles for article (PubMed ID: 12062624)
1. Comparison of methods for calculating rectal dose after (125)I prostate brachytherapy implants.
Hilts M; Spadinger I; Keyes M
Int J Radiat Oncol Biol Phys; 2002 Jul; 53(3):775-85. PubMed ID: 12062624
[TBL] [Abstract][Full Text] [Related]
2. Rectal dosimetric analysis following prostate brachytherapy.
Merrick GS; Butler WM; Dorsey AT; Lief JH; Walbert HL; Blatt HJ
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1021-7. PubMed ID: 10192350
[TBL] [Abstract][Full Text] [Related]
3. Probability of late rectal morbidity in 125I prostate brachytherapy.
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2003 Feb; 55(2):342-53. PubMed ID: 12527047
[TBL] [Abstract][Full Text] [Related]
4. Influence of prostate volume on dosimetry results in real-time 125I seed implantation.
McNeely LK; Stone NN; Presser J; Chircus JH; Stock RG
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):292-9. PubMed ID: 14697451
[TBL] [Abstract][Full Text] [Related]
5. Effect of post-implant edema on the rectal dose in prostate brachytherapy.
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 1999 Oct; 45(3):571-6. PubMed ID: 10524408
[TBL] [Abstract][Full Text] [Related]
6. Prostate seed implantation using 3D-computer assisted intraoperative planning vs. a standard look-up nomogram: Improved target conformality with reduction in urethral and rectal wall dose.
Raben A; Chen H; Grebler A; Geltzeiler J; Geltzeiler M; Keselman I; Litvin S; Sim S; Hanlon A; Yang J
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1631-8. PubMed ID: 15590195
[TBL] [Abstract][Full Text] [Related]
7. Defining the risk of developing grade 2 proctitis following 125I prostate brachytherapy using a rectal dose-volume histogram analysis.
Snyder KM; Stock RG; Hong SM; Lo YC; Stone NN
Int J Radiat Oncol Biol Phys; 2001 Jun; 50(2):335-41. PubMed ID: 11380219
[TBL] [Abstract][Full Text] [Related]
8. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
9. Effect of prostatic edema on CT-based postimplant dosimetry.
Dogan N; Mohideen N; Glasgow GP; Keys K; Flanigan RC
Int J Radiat Oncol Biol Phys; 2002 Jun; 53(2):483-9. PubMed ID: 12023153
[TBL] [Abstract][Full Text] [Related]
10. Influence of organ at risk definition on rectal dose-volume histograms in patients with prostate cancer undergoing external-beam radiotherapy.
Boehmer D; Kuczer D; Badakhshi H; Stiefel S; Kuschke W; Wernecke KD; Budach V
Strahlenther Onkol; 2006 May; 182(5):277-82. PubMed ID: 16673061
[TBL] [Abstract][Full Text] [Related]
11. Comparison of different contouring definitions of the rectum as organ at risk (OAR) and dose-volume parameters predicting rectal inflammation in radiotherapy of prostate cancer: which definition to use?
Nitsche M; Brannath W; Brückner M; Wagner D; Kaltenborn A; Temme N; Hermann RM
Br J Radiol; 2017 Feb; 90(1070):20160370. PubMed ID: 27936891
[TBL] [Abstract][Full Text] [Related]
12. Dose constraint for minimizing grade 2 rectal bleeding following brachytherapy combined with external beam radiotherapy for localized prostate cancer: rectal dose-volume histogram analysis of 457 patients.
Shiraishi Y; Yorozu A; Ohashi T; Toya K; Seki S; Yoshida K; Kaneda T; Saito S; Nishiyama T; Hanada T; Shigematsu N
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e127-33. PubMed ID: 21398047
[TBL] [Abstract][Full Text] [Related]
13. Is it necessary to eliminate the posterior dose margin in prostate brachytherapy to achieve an acceptably low risk of late rectal morbidity?
Waterman FM; Dicker AP
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):293-9. PubMed ID: 12909246
[TBL] [Abstract][Full Text] [Related]
14. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry.
Ohashi T; Yorozu A; Toya K; Saito S; Momma T; Nagata H; Kosugi M
Jpn J Clin Oncol; 2007 Feb; 37(2):121-6. PubMed ID: 17255159
[TBL] [Abstract][Full Text] [Related]
15. Rectal dose constraints for salvage iodine-125 prostate brachytherapy.
Peters M; Hoekstra CJ; van der Voort van Zyp JR; Westendorp H; van de Pol SM; Moerland MA; Maenhout M; Kattevilder R; van Vulpen M
Brachytherapy; 2016; 15(1):85-93. PubMed ID: 26614233
[TBL] [Abstract][Full Text] [Related]
16. Focal or whole-gland salvage prostate brachytherapy with iodine seeds with or without a rectal spacer for postradiotherapy local failure: How best to spare the rectum?
Guimas V; Quivrin M; Bertaut A; Martin E; Chambade D; Maingon P; Mazoyer F; Cormier L; Créhange G
Brachytherapy; 2016; 15(4):406-411. PubMed ID: 27317949
[TBL] [Abstract][Full Text] [Related]
17. Timing of postseed imaging influences rectal dose-volume parameters for cesium-131 prostate seed implants.
Yaparpalvi R; Hannan R; Landau E; Kahan N; Bodner W; Kuo HC; Minsky L; Mehta KJ; Garg MK; Kalnicki S; Guha C
Brachytherapy; 2012; 11(6):489-94. PubMed ID: 21868289
[TBL] [Abstract][Full Text] [Related]
18. Postimplant rectal dosimetry is not dependent on 103Pd or 125I seed activity.
Merrick GS; Sylvester J; Grimm P; Allen ZA; Butler WM; Reed JL; Khanjian J
Brachytherapy; 2011; 10(1):35-43. PubMed ID: 20153264
[TBL] [Abstract][Full Text] [Related]
19. Rectal-wall dose dependence on postplan timing after permanent-seed prostate brachytherapy.
Taussky D; Yeung I; Williams T; Pearson S; McLean M; Pond G; Crook J
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):358-63. PubMed ID: 16563654
[TBL] [Abstract][Full Text] [Related]
20. Comparison of day 0 and day 14 dosimetry for permanent prostate implants using stranded seeds.
McLaughlin P; Narayana V; Pan C; Berri S; Troyer S; Herman J; Evans V; Roberson P
Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):144-50. PubMed ID: 16243441
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
